pgl3-181-htert promoter-luciferase reporter plasmid (Promega)
90
Structured Review
Promega
pgl3-181-htert promoter-luciferase reporter plasmid
Pgl3 181 Htert Promoter Luciferase Reporter Plasmid, supplied by Promega, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pgl3-181/pgl3+basic/pm25798839-222-3-40
Average 90 stars, based on 1 article reviews
Pgl3 181 Htert Promoter Luciferase Reporter Plasmid, supplied by Promega, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pgl3-181/pgl3+basic/pm25798839-222-3-40
Average 90 stars, based on 1 article reviews
pgl3-181-htert promoter-luciferase reporter plasmid - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
Clone Assay:Article Title: Tamoxifen regulates human telomerase reverse transcriptase (hTERT) gene expression differently in breast and endometrial cancer cells. Article Snippet: Tamoxifen is widely applied as an antiestrogenic agent for adjuvant therapy in the treatment of breast cancer, while its estrogen-agonistic activity occasionally causes proliferative disorders or carcinogenesis at other sites, such as the uterus.. We reported that estrogen activates telomerase in breast and endometrial cancer cells.. The present study examines the e ects of tamoxifen on the gene expression of human telomerase reverse transcriptase (hTERT) in breast and endometrial cancer cells. Article Title: Telomerase activation by histone deacetylase inhibitor in normal cells Article Snippet: Plasmid construction pGL3-3328 and pGL3-181 are hTERT promoter-luciferase reporter plasmids in which 3328 and 181 bp sequences upstream of the transcription start site (numbered as +1) as well as a 77 bp 5′-untranslated region are cloned upstream of the luciferase gene (LUC) in Article Title: Telomerase activation by histone deacetylase inhibitor in normal cells Article Snippet: pGL3-3328 and pGL3-181 are hTERT promoter-luciferase reporter plasmids in which 3328 and 181 bp sequences upstream of the transcription start site (numbered as +1) as well as a 77 bp 5′-untranslated region are cloned upstream of the luciferase gene (LUC) in Luciferase:Article Title: Tamoxifen regulates human telomerase reverse transcriptase (hTERT) gene expression differently in breast and endometrial cancer cells. Article Snippet: Tamoxifen is widely applied as an antiestrogenic agent for adjuvant therapy in the treatment of breast cancer, while its estrogen-agonistic activity occasionally causes proliferative disorders or carcinogenesis at other sites, such as the uterus.. We reported that estrogen activates telomerase in breast and endometrial cancer cells.. The present study examines the e ects of tamoxifen on the gene expression of human telomerase reverse transcriptase (hTERT) in breast and endometrial cancer cells. Article Title: Telomerase activation by histone deacetylase inhibitor in normal cells Article Snippet: Plasmid construction pGL3-3328 and pGL3-181 are hTERT promoter-luciferase reporter plasmids in which 3328 and 181 bp sequences upstream of the transcription start site (numbered as +1) as well as a 77 bp 5′-untranslated region are cloned upstream of the luciferase gene (LUC) in Article Title: Telomerase activation by histone deacetylase inhibitor in normal cells Article Snippet: pGL3-3328 and pGL3-181 are hTERT promoter-luciferase reporter plasmids in which 3328 and 181 bp sequences upstream of the transcription start site (numbered as +1) as well as a 77 bp 5′-untranslated region are cloned upstream of the luciferase gene (LUC) in Construct:Article Title: Tamoxifen regulates human telomerase reverse transcriptase (hTERT) gene expression differently in breast and endometrial cancer cells. Article Snippet: Tamoxifen is widely applied as an antiestrogenic agent for adjuvant therapy in the treatment of breast cancer, while its estrogen-agonistic activity occasionally causes proliferative disorders or carcinogenesis at other sites, such as the uterus.. We reported that estrogen activates telomerase in breast and endometrial cancer cells.. The present study examines the e ects of tamoxifen on the gene expression of human telomerase reverse transcriptase (hTERT) in breast and endometrial cancer cells. Article Title: Telomerase activation by histone deacetylase inhibitor in normal cells Article Snippet: Plasmid construction pGL3-3328 and pGL3-181 are hTERT promoter-luciferase reporter plasmids in which 3328 and 181 bp sequences upstream of the transcription start site (numbered as +1) as well as a 77 bp 5′-untranslated region are cloned upstream of the luciferase gene (LUC) in Article Title: Telomerase activation by histone deacetylase inhibitor in normal cells Article Snippet: pGL3-3328 and pGL3-181 are hTERT promoter-luciferase reporter plasmids in which 3328 and 181 bp sequences upstream of the transcription start site (numbered as +1) as well as a 77 bp 5′-untranslated region are cloned upstream of the luciferase gene (LUC) in Plasmid Preparation:Article Title: Tamoxifen regulates human telomerase reverse transcriptase (hTERT) gene expression differently in breast and endometrial cancer cells. Article Snippet: Tamoxifen is widely applied as an antiestrogenic agent for adjuvant therapy in the treatment of breast cancer, while its estrogen-agonistic activity occasionally causes proliferative disorders or carcinogenesis at other sites, such as the uterus.. We reported that estrogen activates telomerase in breast and endometrial cancer cells.. The present study examines the e ects of tamoxifen on the gene expression of human telomerase reverse transcriptase (hTERT) in breast and endometrial cancer cells. Article Title: Telomerase activation by histone deacetylase inhibitor in normal cells Article Snippet: Plasmid construction pGL3-3328 and pGL3-181 are hTERT promoter-luciferase reporter plasmids in which 3328 and 181 bp sequences upstream of the transcription start site (numbered as +1) as well as a 77 bp 5′-untranslated region are cloned upstream of the luciferase gene (LUC) in Article Title: Telomerase activation by histone deacetylase inhibitor in normal cells Article Snippet: pGL3-3328 and pGL3-181 are hTERT promoter-luciferase reporter plasmids in which 3328 and 181 bp sequences upstream of the transcription start site (numbered as +1) as well as a 77 bp 5′-untranslated region are cloned upstream of the luciferase gene (LUC) in Expressing:Article Title: Tamoxifen regulates human telomerase reverse transcriptase (hTERT) gene expression differently in breast and endometrial cancer cells. Article Snippet: Tamoxifen is widely applied as an antiestrogenic agent for adjuvant therapy in the treatment of breast cancer, while its estrogen-agonistic activity occasionally causes proliferative disorders or carcinogenesis at other sites, such as the uterus.. We reported that estrogen activates telomerase in breast and endometrial cancer cells.. The present study examines the e ects of tamoxifen on the gene expression of human telomerase reverse transcriptase (hTERT) in breast and endometrial cancer cells. Article Title: Telomerase activation by histone deacetylase inhibitor in normal cells Article Snippet: Plasmid construction pGL3-3328 and pGL3-181 are hTERT promoter-luciferase reporter plasmids in which 3328 and 181 bp sequences upstream of the transcription start site (numbered as +1) as well as a 77 bp 5′-untranslated region are cloned upstream of the luciferase gene (LUC) in Article Title: Telomerase activation by histone deacetylase inhibitor in normal cells Article Snippet: pGL3-3328 and pGL3-181 are hTERT promoter-luciferase reporter plasmids in which 3328 and 181 bp sequences upstream of the transcription start site (numbered as +1) as well as a 77 bp 5′-untranslated region are cloned upstream of the luciferase gene (LUC) in Transfection:Article Title: Tamoxifen regulates human telomerase reverse transcriptase (hTERT) gene expression differently in breast and endometrial cancer cells. Article Snippet: Tamoxifen is widely applied as an antiestrogenic agent for adjuvant therapy in the treatment of breast cancer, while its estrogen-agonistic activity occasionally causes proliferative disorders or carcinogenesis at other sites, such as the uterus.. We reported that estrogen activates telomerase in breast and endometrial cancer cells.. The present study examines the e ects of tamoxifen on the gene expression of human telomerase reverse transcriptase (hTERT) in breast and endometrial cancer cells. Article Title: Telomerase activation by histone deacetylase inhibitor in normal cells Article Snippet: Plasmid construction pGL3-3328 and pGL3-181 are hTERT promoter-luciferase reporter plasmids in which 3328 and 181 bp sequences upstream of the transcription start site (numbered as +1) as well as a 77 bp 5′-untranslated region are cloned upstream of the luciferase gene (LUC) in Article Title: Telomerase activation by histone deacetylase inhibitor in normal cells Article Snippet: pGL3-3328 and pGL3-181 are hTERT promoter-luciferase reporter plasmids in which 3328 and 181 bp sequences upstream of the transcription start site (numbered as +1) as well as a 77 bp 5′-untranslated region are cloned upstream of the luciferase gene (LUC) in Incubation:Article Title: Tamoxifen regulates human telomerase reverse transcriptase (hTERT) gene expression differently in breast and endometrial cancer cells. Article Snippet: Tamoxifen is widely applied as an antiestrogenic agent for adjuvant therapy in the treatment of breast cancer, while its estrogen-agonistic activity occasionally causes proliferative disorders or carcinogenesis at other sites, such as the uterus.. We reported that estrogen activates telomerase in breast and endometrial cancer cells.. The present study examines the e ects of tamoxifen on the gene expression of human telomerase reverse transcriptase (hTERT) in breast and endometrial cancer cells. Article Title: Telomerase activation by histone deacetylase inhibitor in normal cells Article Snippet: Plasmid construction pGL3-3328 and pGL3-181 are hTERT promoter-luciferase reporter plasmids in which 3328 and 181 bp sequences upstream of the transcription start site (numbered as +1) as well as a 77 bp 5′-untranslated region are cloned upstream of the luciferase gene (LUC) in Article Title: Telomerase activation by histone deacetylase inhibitor in normal cells Article Snippet: pGL3-3328 and pGL3-181 are hTERT promoter-luciferase reporter plasmids in which 3328 and 181 bp sequences upstream of the transcription start site (numbered as +1) as well as a 77 bp 5′-untranslated region are cloned upstream of the luciferase gene (LUC) in Activity Assay:Article Title: Tamoxifen regulates human telomerase reverse transcriptase (hTERT) gene expression differently in breast and endometrial cancer cells. Article Snippet: Tamoxifen is widely applied as an antiestrogenic agent for adjuvant therapy in the treatment of breast cancer, while its estrogen-agonistic activity occasionally causes proliferative disorders or carcinogenesis at other sites, such as the uterus.. We reported that estrogen activates telomerase in breast and endometrial cancer cells.. The present study examines the e ects of tamoxifen on the gene expression of human telomerase reverse transcriptase (hTERT) in breast and endometrial cancer cells. Article Title: Telomerase activation by histone deacetylase inhibitor in normal cells Article Snippet: Plasmid construction pGL3-3328 and pGL3-181 are hTERT promoter-luciferase reporter plasmids in which 3328 and 181 bp sequences upstream of the transcription start site (numbered as +1) as well as a 77 bp 5′-untranslated region are cloned upstream of the luciferase gene (LUC) in Article Title: Telomerase activation by histone deacetylase inhibitor in normal cells Article Snippet: pGL3-3328 and pGL3-181 are hTERT promoter-luciferase reporter plasmids in which 3328 and 181 bp sequences upstream of the transcription start site (numbered as +1) as well as a 77 bp 5′-untranslated region are cloned upstream of the luciferase gene (LUC) in Dominant Negative Mutation:Article Title: Tamoxifen regulates human telomerase reverse transcriptase (hTERT) gene expression differently in breast and endometrial cancer cells. Article Snippet: Tamoxifen is widely applied as an antiestrogenic agent for adjuvant therapy in the treatment of breast cancer, while its estrogen-agonistic activity occasionally causes proliferative disorders or carcinogenesis at other sites, such as the uterus.. We reported that estrogen activates telomerase in breast and endometrial cancer cells.. The present study examines the e ects of tamoxifen on the gene expression of human telomerase reverse transcriptase (hTERT) in breast and endometrial cancer cells. Article Title: Telomerase activation by histone deacetylase inhibitor in normal cells Article Snippet: Plasmid construction pGL3-3328 and pGL3-181 are hTERT promoter-luciferase reporter plasmids in which 3328 and 181 bp sequences upstream of the transcription start site (numbered as +1) as well as a 77 bp 5′-untranslated region are cloned upstream of the luciferase gene (LUC) in Article Title: Telomerase activation by histone deacetylase inhibitor in normal cells Article Snippet: pGL3-3328 and pGL3-181 are hTERT promoter-luciferase reporter plasmids in which 3328 and 181 bp sequences upstream of the transcription start site (numbered as +1) as well as a 77 bp 5′-untranslated region are cloned upstream of the luciferase gene (LUC) in |